Cite
Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease.
MLA
Alisi, Anna, et al. “Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease.” PLoS ONE, vol. 8, no. 6, June 2013, pp. 1–9. EBSCOhost, https://doi.org/10.1371/journal.pone.0067160.
APA
Alisi, A., Ceccarelli, S., Panera, N., Prono, F., Petrini, S., De Stefanis, C., Pezzullo, M., Tozzi, A., Villani, A., Bedogni, G., & Nobili, V. (2013). Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease. PLoS ONE, 8(6), 1–9. https://doi.org/10.1371/journal.pone.0067160
Chicago
Alisi, Anna, Sara Ceccarelli, Nadia Panera, Federica Prono, Stefania Petrini, Cristiano De Stefanis, Marco Pezzullo, et al. 2013. “Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease.” PLoS ONE 8 (6): 1–9. doi:10.1371/journal.pone.0067160.